NYSE:DLB Dolby Laboratories (DLB) Stock Price, News & Analysis $62.94 -0.34 (-0.54%) Closing price 10/23/2026 03:59 PM EasternExtended Trading$62.85 -0.09 (-0.14%) As of 10/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Dolby Laboratories Stock (NYSE:DLB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Dolby Laboratories alerts:Sign Up Key Stats Today's Range$62.46▼$63.3850-Day Range$57.10▼$66.2752-Week Range$48.26▼$69.95Volume454,852 shsAverage Volume632,494 shsMarket Capitalization$5.90 billionP/E Ratio26.78Dividend Yield2.29%Price Target$87.50Consensus RatingHold Company Overview Dolby Laboratories, Inc. develops audio and imaging technologies used to enhance entertainment and communications experiences. The company’s technologies are incorporated into cinema, television, broadcast, streaming, mobile, personal computer, automotive and gaming products and services. Its principal offerings include Dolby Atmos, an object-based audio technology designed to create immersive sound, and Dolby Vision, a high-dynamic-range imaging technology intended to improve picture quality. Dolby also develops and licenses technologies for audio encoding, decoding, processing and transmission, including solutions used by content creators, distributors, device manufacturers and entertainment platforms. Founded in 1965 by Ray Dolby, the company initially became known for its noise-reduction technology and later expanded into cinema sound and digital media technologies. Dolby Laboratories is headquartered in San Francisco and serves customers and audiences worldwide through technology licensing, product development and partnerships across the entertainment and consumer-electronics industries. Kevin Yeaman has served as Dolby Laboratories’ president and chief executive officer since 2009. The company’s technologies are delivered through licensing arrangements and are integrated into products and services from a broad range of global content, technology and device companies.AI Generated. May Contain Errors. Read More Dolby Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks83rd Percentile Overall ScoreDLB MarketRank™: 4.139503688795 of 5 starsDolby Laboratories scored higher than 83% of companies evaluated by MarketBeat, and ranked 147th out of 590 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingHold Consensus RatingDolby Laboratories has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialDolby Laboratories has a consensus price target of $87.50, representing about 39.0% upside from its current price of $62.94.Amount of Analyst CoverageDolby Laboratories has only been the subject of 3 research reports in the past 90 days.Read more about Dolby Laboratories' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth4.02% Earnings GrowthEarnings for Dolby Laboratories are expected to grow by 4.02% in the coming year, from $3.23 to $3.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Dolby Laboratories is 26.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.38.Price to Earnings Ratio vs. SectorThe P/E ratio of Dolby Laboratories is 26.78, which means that it is trading at a less expensive P/E ratio than the Technology sector average P/E ratio of about 78.36.Price to Book Value per Share RatioDolby Laboratories has a P/B Ratio of 2.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Dolby Laboratories' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.21% of the float of Dolby Laboratories has been sold short.Short Interest Ratio / Days to CoverDolby Laboratories has a short interest ratio ("days to cover") of 5.86.Change versus previous monthShort interest in Dolby Laboratories has recently increased by 7.36%, indicating that investor sentiment is decreasing significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldDolby Laboratories pays a meaningful dividend of 2.28%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthDolby Laboratories has been increasing its dividend for 10 years.Dividend CoverageThe dividend payout ratio of Dolby Laboratories is 61.28%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 42.86% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.Read more about Dolby Laboratories' dividend. News and Social Media1.4 / 5News Sentiment0.31 News SentimentDolby Laboratories has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Dolby Laboratories this week, compared to 4 articles on an average week. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Dolby Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,749,388.00 in company stock.Percentage Held by Insiders37.93% of the stock of Dolby Laboratories is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions58.56% of the stock of Dolby Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Dolby Laboratories' insider trading history. Receive DLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dolby Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DLB Stock News HeadlinesBarrington Reaffirms Their Buy Rating on Dolby Laboratories (DLB)October 20, 2026 | theglobeandmail.comDolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial ResultsOctober 12, 2026 | prnewswire.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.October 25 at 1:00 AM | Weiss Ratings (Ad)Dolby Laboratories' Atmos Spatial Audio to Be Used on Apple TV's Formula 1 BroadcastsOctober 7, 2026 | finance.yahoo.comDolby Laboratories: Weak Growth, But The Valuation Is Too CheapOctober 5, 2026 | seekingalpha.comDolby Laboratories (DLB) Could Be 27% Below Fair Value After Meta ExpansionSeptember 25, 2026 | finance.yahoo.comDolby sta per aggiungere un importante aggiornamento ai tuoi occhiali Meta AI: ecco di cosa si trattaSeptember 24, 2026 | it.finance.yahoo.comHow Meta’s Expanded Dolby Atmos and Vision Integration At Dolby Laboratories (DLB) Has Changed Its Investment StorySeptember 24, 2026 | finance.yahoo.comSee More Headlines DLB Stock Analysis - Frequently Asked Questions How have DLB shares performed this year? Dolby Laboratories' stock was trading at $64.22 at the beginning of 2026. Since then, DLB stock has decreased by 2.0% and is now trading at $62.9390. How were Dolby Laboratories' earnings last quarter? Dolby Laboratories (NYSE:DLB) released its quarterly earnings data on Thursday, July, 30th. The electronics maker reported $0.69 EPS for the quarter, beating analysts' consensus estimates of $0.67 by $0.02. The company's revenue for the quarter was down 3.3% compared to the same quarter last year. Read the conference call transcript. How will Dolby Laboratories' stock buyback program work? Dolby Laboratories' board authorized a stock buyback plan on Thursday, July 30th 2026, which authorizes the company to repurchase $350,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 7% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its stock is undervalued. Does Dolby Laboratories have any subsidiaries? Dolby Laboratories subsidiaries include Voxeet, Doremi Labs, Step Labs, Coding Technologies, Dolby International AB, and Dolby Laboratories Licensing Corporation. Who are Dolby Laboratories' major shareholders? Dolby Laboratories' top institutional shareholders include Robeco Institutional Asset Management B.V. (0.39%), Ninety One UK Ltd (0.34%), Vest Financial LLC (0.15%) and Cardinal Capital Management (0.06%). Insiders that own company stock include John D Couling, Kevin J Yeaman, Robert J Park, Shriram Revankar, Mark Andrew Sherman, Todd Pendleton and Ryan Nicholson. View institutional ownership trends. How do I buy shares of Dolby Laboratories? Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Dolby Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dolby Laboratories investors own include NVIDIA (NVDA), Netflix (NFLX), Applied Materials (AMAT), Advanced Micro Devices (AMD), Visa (V), Cisco Systems (CSCO) and Micron Technology (MU). Company Calendar Last Earnings7/30/2026Record date for 8/19 Dividend8/11/2026Ex-Dividend for 8/19 Dividend8/11/2026Dividend Payable8/19/2026Today10/25/2026Next Earnings (Estimated)11/17/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 10 days, DLB's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorTechnology Industry Software Sub-IndustrySystems Software Current SymbolNYSE:DLB CIK1308547 Webwww.dolby.com Phone(415) 558-0200Fax415-645-4000Employees2,051Year Founded1965Price Target and Rating Average Price Target for Dolby Laboratories$87.50 High Price Target$90.00 Low Price Target$85.00 Potential Upside/Downside+39.0%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$2.35 Trailing P/E Ratio26.78 Forward P/E Ratio19.49 P/E GrowthN/ANet Income$255.02 million Net Margins16.70% Pretax Margin20.44% Return on Equity11.08% Return on Assets9.04% Debt Debt-to-Equity RatioN/A Current Ratio3.19 Quick Ratio3.11 Sales & Book Value Annual Sales$1.35 billion Price / Sales4.35 Cash Flow$4.28 per share Price / Cash Flow14.72 Book Value$27.56 per share Price / Book2.28Miscellaneous Outstanding Shares93,669,000Free Float58,140,000Market Cap$5.90 billion OptionableOptionable Beta0.78 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NYSE:DLB) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredCigar Lake Flooded Again Uranium Supply Shock RepeatsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dolby Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Dolby Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.